Published February 1982
by S. Karger AG (Switzerland) .
Written in English
|The Physical Object|
|Number of Pages||130|
A one-stop shop, covering everything a doctor, teacher or trainee will ever need to know about neuropsychopharmacology. Featuring Patrick Finley PharmD from UCSF Summary. Dive deep into the psychopharmacology of depression with Dr Patrick Finley, PharmD at UCSF. Learn practical tips including how to switch from one antidepressant to another, what to expect with SSRI and SNRI withdrawal, and how to choose a second (or third) antidepressant for refractory depression. The American Psychiatric Association Publishing Textbook of Psychopharmacology is an indispensable and comprehensive resource for clinicians and trainees who prescribe psychotropic medications. Updated to reflect the new DSM-5 classification, this revised Fifth Edition maintains the user-friendly structure of its predecessors while offering in-depth coverage of the latest research in. Psychopharmacology: #N# What Is Psychopharmacology?#N# #N#.
This literature review will examine antidepressants as a treatment of depression. The aim of this article is to also discuss the uses of various pharmaceutical treatments that may not typically be used to treat depression. The review will describe how antidepressants influence the chemical structure of the brain to alleviate depression, their overall effects on the individual, and an analysis. Essential Psychopharmacology of Depression and Bipolar Disorder book. Read reviews from world’s largest community for readers. Essential Psychopharmacolo /5. Psychopharmacology is the use of psychotropic medications (any prescription meds that affect mood, emotion, behavior, or perception) to treat mental illness. In the case of bipolar, psychopharmacology has four primary goals: Alleviate acute manic symptoms Ease depressive symptoms Eliminate or lessen any psychosis Maintain mood stability and reduce the likelihood or frequency of future mood [ ]. Drug therapies for depression. Clinical psychopharmacology of depression is very effective. Approximately 60–70% of people with depression respond to pharmacotherapy, and rates go up to 80% if limited to mild or moderate major depressive disorder.
ISBN: OCLC Number: Description: x, pages: illustrations ; 25 cm. Contents: The epidemiology of depressive illness / Paul Bebbington --Second generation antidepressants: chemical diversity but unity of action?/ B.E. Leonard --Animal studies on neuropeptides and depression / Jan M. Van Ree, Cécile Durlach-Misteli, and Raymond J.M. Niesink --Disturbed. This book comes 5 years after the last edition. The remaining 11 chapters cover the main domains of psychiatric psychopharmacology, and the author has cleverly supplemented the basic neuroscience of the former introductory chapters into the clinical chapters without overburdening the reader. (lamotrigine plus quetiapine) may be a useful. Psychopharmacology Updates for Prescribers. Access exclusive content and earn CME credits with a Premium or Premium Plus Membership. Get full access. RECENT PUBLICATIONS. Loading recent publications. You can access more than 0 video lectures, podcasts, research summaries and expert interviews. We publish new content every month. Neuro-psychopharmacology covers the proceedings of the 11th Congress of the Collegium Internationale Neuro-psychopharmacologicum, held in Vienna on July , The book focuses on the processes, methodologies, and approaches in neuropsychopharmacology.